Axogen, Inc. Payments of Stock Issuance Costs
Axogen, Inc. (AXGN) reported Payments of Stock Issuance Costs of $792.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-07-29
- Axogen, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00.
- Axogen, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $792.00K.
- Axogen, Inc. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
- Axogen, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $0.00.
- Axogen, Inc. payments of stock issuance costs for fiscal 2022 was $0.00.
- Axogen, Inc. payments of stock issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Axogen, Inc. payments of stock issuance costs for fiscal 2020 was $642.00K.
- Axogen, Inc. payments of stock issuance costs for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 6 month as first filed | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $792.00K 10-Q · filed 2026-07-29 | |||||
| 2026-03-31 | $792.00K 10-Q · filed 2026-04-28 | ||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $0.00 10-Q · filed 2026-07-29 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-28 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2023-03-14 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-14 | ||||||
| 2020-12-31 | $642.00K 10-K · filed 2023-03-14 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $257.00K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $257.00K 10-Q · filed 2019-11-06 | $256.77K 10-Q · filed 2018-10-29 | ||||
| 2018-06-30 | $257.00K 10-Q · filed 2019-08-06 | $256.77K 10-Q · filed 2018-08-01 | |||||
| 2017-12-31 | $228.00K 10-K · filed 2020-02-24 | ||||||
| 2016-12-31 | $99.00K 10-K · filed 2019-02-26 | ||||||
| 2013-09-30 | $1.80 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |